Former Michigan Medicine dean omitted multimillion-dollar pharma ties in multiple publications, Daily investigation finds The Michigan Daily Nawigacja wpisu FDA issues complete response letter to Disc Medicine’s bitopertin NDA – Pharmaceutical Technology A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial – Nature
